Armata Pharmaceuticals (ARMP) Invested Capital (2018 - 2026)
Armata Pharmaceuticals (ARMP) posted Invested Capital of $48.1 million for Q3 2025, up 43.78% sequentially from $33.4 million in Q2 2025, and up 16.28% YoY from $41.4 million in Q3 2024.
Armata Pharmaceuticals (ARMP) Invested Capital (2018 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported Invested Capital for 5 years, with the latest figure at $48.1 million in Q3 2025.
- Quarterly Invested Capital rose 16.28% year-over-year to $48.1 million in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $81.5 million (down 30.5% YoY) and the FY2020 annual result came in at $1.9 million, up 100.0% from the prior year.
- Invested Capital rose to $48.1 million in Q3 2025 per ARMP's latest filing, from $33.4 million in the prior quarter.
- Over five years, Invested Capital peaked at $71.7 million in Q1 2024 and troughed at $27.7 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Armata Pharmaceuticals | 182.82 Mn | 158.82 Mn | - | 163.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 163.90 Mn |
| Sep 30, 2025 | 48.09 Mn |
| Jun 30, 2025 | 33.45 Mn |
| Mar 31, 2025 | 27.69 Mn |
| Sep 30, 2024 | 41.36 Mn |
| Jun 30, 2024 | 48.26 Mn |
| Mar 31, 2024 | 71.66 Mn |
| Dec 31, 2020 | 1.94 Mn |
| Sep 30, 2020 | 1.77 Mn |
| Jun 30, 2020 | 1.62 Mn |
| Mar 31, 2020 | 1.48 Mn |
| Dec 31, 2019 | 970,000.00 |
| Sep 30, 2019 | 885,000.00 |
| Jun 30, 2019 | 769,000.00 |
| Dec 31, 2018 | 970,000.00 |